AIMS: Since many biomarkers of both the tumor and its microenvironment are expected to involve differential expression of divalent proteins capable of protein or peptide ligand interaction, we are developing multivalent nanodevices for the identification of biomarkers in prostate cancer. PATIENTS & METHODS: We compared a multivalent thioredoxin-targeted nanodevice with monovalent thioredoxin in binding to human prostate cell line(s) and freshly frozen tissue specimens obtained after resection from patients with biopsy-proven prostate cancer. CONCLUSION: The nanodevice binds specifically with enhanced avidity to tumor microenvironment-associated stromal cells in prostate cancer tissue specimens. Cells that bind the nanodevice also reacted with antibodies to dimeric thioredoxin reductases 1 and 2, suggesting the utility of the nanodevice as a potentially specific and functional marker of tumor stromal cells.
AIMS: Since many biomarkers of both the tumor and its microenvironment are expected to involve differential expression of divalent proteins capable of protein or peptide ligand interaction, we are developing multivalent nanodevices for the identification of biomarkers in prostate cancer. PATIENTS & METHODS: We compared a multivalent thioredoxin-targeted nanodevice with monovalent thioredoxin in binding to human prostate cell line(s) and freshly frozen tissue specimens obtained after resection from patients with biopsy-proven prostate cancer. CONCLUSION: The nanodevice binds specifically with enhanced avidity to tumor microenvironment-associated stromal cells in prostate cancer tissue specimens. Cells that bind the nanodevice also reacted with antibodies to dimeric thioredoxin reductases 1 and 2, suggesting the utility of the nanodevice as a potentially specific and functional marker of tumor stromal cells.
Authors: Jarrod Clark; Taras Shevchuk; Piotr M Swiderski; Rajesh Dabur; Laura E Crocitto; Yaroslav I Buryanov; Steven S Smith Journal: Biotechniques Date: 2003-09 Impact factor: 1.993
Authors: Diane S Lidke; Peter Nagy; Rainer Heintzmann; Donna J Arndt-Jovin; Janine N Post; Hernan E Grecco; Elizabeth A Jares-Erijman; Thomas M Jovin Journal: Nat Biotechnol Date: 2004-01-04 Impact factor: 54.908
Authors: Christopher Whelan; Mark Kawachi; David D Smith; Jennifer Linehan; Gail Babilonia; Rosa Mejia; Timothy Wilson; Steven S Smith Journal: J Urol Date: 2013-05-10 Impact factor: 7.450
Authors: Elizabeth Singer; Jennifer Linehan; Gail Babilonia; S Ashraf Imam; David Smith; Sofia Loera; Timothy Wilson; Steven Smith Journal: PLoS One Date: 2013-06-06 Impact factor: 3.240